Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab

Novel predictive biomarkers are needed to improve patient selection and optimize the use of bevacizumab (B) in metastatic colorectal cancer. We analyzed the potential of five circulating biomarkers to predict B efficacy and monitor response. Peripheral blood samples collected at baseline, at the fir...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Marisi, Giorgia, Scarpi, Emanuela, Passardi, Alessandro, Nanni, Oriana, Ragazzini, Angela, Valgiusti, Martina, Casadei Gardini, Andrea, Neri, Luca Maria, Frassineti, Giovanni Luca, Amadori, Dino, Ulivi, Paola
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5431064/
https://ncbi.nlm.nih.gov/pubmed/28465540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-01420-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky